DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Loi S. et al.
Tumor-infiltrating lymphocytes are predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.
Ann Oncol 2014;
25: 1544-1550
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.